The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...
Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback